Boosting immunogenic cell death via hollow MnO2-based multiple stimuli-responsive drug delivery systems for improved cancer immunotherapy
This study overcame the limitations of monotherapy and provided a multifunctional platform for tumor immunotherapy.
Source: Cancer Nanotechnology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Environmental Health | Immunotherapy | Manganese | Nanotechnology | Study